The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Medvedev V.E.

Department of Psychiatry, Psychotherapy and Psychosomatic Pathology of the Peoples' Friendship University of Russia

Retyunskiy K.Yu.

Ural State Medical University, Ekaterinburg

Ovchinnikov A.A.

Novosibirsk State Medical University, Novosibirsk, Russia

Baryl'nik Iu.B.

GBOU VPO "Saratovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. V.I. Razumovskogo, Saratov

Shmilovich A.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Antokhin E.Yu.

Orenburg State Medical University, Orenburg, Russia

Usov G.M.

Omsk State Medical Academy, Omsk, Russia

Cheremin R.A.

Moskovskaia gorodskaia psikhiatricheskaia bol'nitsa #10, Moskva

Poletsky V.M.

South Ural State Medical University, Chelyabinsk, Russia

Onegin A.V.

Murmansk Regional Psychoneurological Dispensary, Murmansk, Russia

Kireeva I.P.

Pirogov National Research Medical University, Moscow, Russia

Frolova V.I.

Kafedra psikhiatrii, psikhoterapii i psikhosomaticheskoĭ patologii fakul'teta povysheniia kvalifikatsii meditsinskikh rabotnikov Rossiĭskogo universiteta druzhby narodov

Filippova N.V.

GBOU VPO "Saratovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. V.I. Razumovskogo, Saratov

Antonova A.A.

Razumovsky Saratov State Medical University, Saratov, Russia

Deeva M.A.

Razumovsky Saratov State Medical University, Saratov, Russia

Onegina D.A.

Murmansk Regional Psychoneurological Dispensary, Murmansk, Russia

The differences in the estimation of depression severity by psychiatrists and patients during the combined treatment with agomelatine (a multicenter study “EMOTSIA”)

Authors:

Medvedev V.E., Retyunskiy K.Yu., Ovchinnikov A.A., Baryl'nik Iu.B., Shmilovich A.A., Antokhin E.Yu., Usov G.M., Cheremin R.A., Poletsky V.M., Onegin A.V., Kireeva I.P., Frolova V.I., Filippova N.V., Antonova A.A., Deeva M.A., Onegina D.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(11): 26‑34

DOI: 10.17116/jnevro201611611126-34

Views: 1015

Downloaded: 18

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Medvedev VE, Retyunskiy KYu, Ovchinnikov AA, et al. . The differences in the estimation of depression severity by psychiatrists and patients during the combined treatment with agomelatine (a multicenter study “EMOTSIA”). S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(11):26‑34. (In Russ.)
https://doi.org/10.17116/jnevro201611611126-34

 
МСФ на ЯМ
Close metadata
Recommended articles:
The effect of inso­mnia on mild cognitive impairment in patients with vascular risks: resu­lts of a three-year longitudinal study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):30-36
A perspective on the application of CRISPR/CAS9 genome editing system to study of mole­cular-genetic basis of mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):27-33
Vali­dation of screening method based on EEG analysis for the risk asse­ssment of psychiatric and beha­vioral diso­rders: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):88-96
A clinical case of the new-onset bipo­lar affe­ctive diso­rder in the postcovid period. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):125-129
Pathogenetic basis of modern approaches to the therapy of sleep diso­rders in the clinic of depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):69-74
Features of the clinical picture of affe­ctive diso­rders in women during the meno­pausal transition and early postmenopause. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):75-79
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Sleep diso­rders and onco­logical diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):125-131
Clinical and epidemiological features of atopic type of alopecia areata. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(2):155-160

Objective: To compare the prognosis of depression severity estimated by the physician and by the patient based on the treatment outcome. Material and methods: One hundred and seven patients with depression were examined. Mental status was assessed with HАМ-D, SHAPS, CGI-S, CGI-I, PGI-S, PGI-I and VAS. A data analysis was performed. Results: There were differences in the estimation of depression severity by psychiatrists and patients. Moreover, the scores on HАМ-D and CGI-S were not consistent when assessed by psychiatrists. As the severity of depression decreased and patient’s state improved during the treatment with agomelatine (valdoxan), the assessments of the changes by the psychiatrist and the patient became similar. Conclusion: Agomelatine (valdoxan) is effective and tolerable in the treatment of depression of any severity. The differences between the psychiatrist’s and patient’s estimation of the depression severity at baseline using different psychometric scales can level the prognostic value of treatment outcome.

Keywords:

depression
severity
scales
agomelatine

Authors:

Medvedev V.E.

Department of Psychiatry, Psychotherapy and Psychosomatic Pathology of the Peoples' Friendship University of Russia

Retyunskiy K.Yu.

Ural State Medical University, Ekaterinburg

Ovchinnikov A.A.

Novosibirsk State Medical University, Novosibirsk, Russia

Baryl'nik Iu.B.

GBOU VPO "Saratovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. V.I. Razumovskogo, Saratov

Shmilovich A.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Antokhin E.Yu.

Orenburg State Medical University, Orenburg, Russia

Usov G.M.

Omsk State Medical Academy, Omsk, Russia

Cheremin R.A.

Moskovskaia gorodskaia psikhiatricheskaia bol'nitsa #10, Moskva

Poletsky V.M.

South Ural State Medical University, Chelyabinsk, Russia

Onegin A.V.

Murmansk Regional Psychoneurological Dispensary, Murmansk, Russia

Kireeva I.P.

Pirogov National Research Medical University, Moscow, Russia

Frolova V.I.

Kafedra psikhiatrii, psikhoterapii i psikhosomaticheskoĭ patologii fakul'teta povysheniia kvalifikatsii meditsinskikh rabotnikov Rossiĭskogo universiteta druzhby narodov

Filippova N.V.

GBOU VPO "Saratovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. V.I. Razumovskogo, Saratov

Antonova A.A.

Razumovsky Saratov State Medical University, Saratov, Russia

Deeva M.A.

Razumovsky Saratov State Medical University, Saratov, Russia

Onegina D.A.

Murmansk Regional Psychoneurological Dispensary, Murmansk, Russia

List of references:

  1. Mosolov SN. (red.) Biologicheskie metody terapii psihicheskih rasstrojstv (dokazatel'naja medicina — klinicheskoj praktike). M.: Social'no-politicheskaja mysl'; 2012. (In Russ.).
  2. Smulevich AB. Depressija pri psihicheskih i somaticheskih zabolevanijah (4-e izd.). M.: MIA; 2015. (In Russ.).
  3. Cirkin SJu. Analiticheskaja psihopatologija. 3-e izd. M.: Izdatel'stvo BINOM; 2012. (In Russ.).
  4. Chenu F, El Mansari M, Blier P. Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine, and serotonin systems in the rat brain. Neuropsychopharmacology. 2013;38(2):275-284. doi: 10.1038/npp.2012.140
  5. Molteni R, Calabrese F, Pisoni S, Gabriel C, Mocaer E, Racagni G, Riva MA. Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration. World J Biol Psychiatry. 2010;11(2):148-153. doi: 10.3109/15622970903447659
  6. Racagni G, Riva M, Molteni R, Musazzi L, Calabrese F, Popoli M, Tardito D. Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors. World J Biol Psychiatry. 2011;12(8):574-587. doi: 10.3109/15622975.2011.595823
  7. Reagan L, Reznikov L, Evans A. Gabriel C, Mocaër E, Fadel JR. The antidepressant agomelatine inhibits stress-mediated changes in amino acid efflux in the rat hippocampus and amygdala. Brain Res. 2012;1466:91-98. doi: 10.1016/j.brainres.2012.05.039
  8. Soumier A, Banasr M, Lortet S, Masmejean F, Bernard N, Kerkerian-Le-Goff L, Gabriel C, Millan MJ, Mocaer E, Daszuta A. Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus. Neuropsychopharmacology. 2009;34(11):2390-2403. doi: 10.1038/npp.2009.72
  9. Stahl SM. Essential psychopharmacology. Cambridge Medicine. 2013;608.
  10. Stahl SM. Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic properties. CNS Spectr. 2014;19(3):207-212. doi: 10.1017/S1092852914000248
  11. Tardito D, Milanese M, Bonifacino T, Musazzi L, Grilli M, Mallei A, Mocaer E, Gabriel-Gracia C, Racagni G, Popoli M, Bonanno G. Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways. BMC Neurosci. 2010;11:68. doi: 10.1186/1471-2202-11-68
  12. Avedisova AS, Zaharova KV, Marachev MP. Rezul'taty observacionnoj programmy DZhAZ: remissija, prediktory ee formirovanija i perenosimost' Val'doksana (agomelatina) u pacientov s trevozhnoj depressiej v ramkah bol'shogo depressivnogo rasstrojstva. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2014;4:4-9. (In Russ.).
  13. Antonova AA. Sravnitel'nyj analiz terapii nepsihoticheskih psihicheskih rasstrojstv u zhenshhin v perimenopauze po pokazateljam kachestva zhizni [Jelektronnyj resurs]. Sovremennye problemy nauki i obrazovanija. 2015;5: Dostupno po: http://www.science-education.ru/128-22685. (In Russ.).
  14. Antohin EJu. Terapija tjazheloj rekurrentnoj depressii. Psihiatrija i psihofarmakoterapija. 2010;6:18-23. (In Russ.).
  15. Antohin EJu, Harina EA. Bipoljarnoe affektivnoe rasstrojstvo tipa II: osobennosti kliniki i vozmozhnosti kompleksnoj terapii, vkljuchajushhej Val'doksan. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2013;3:24-32. (In Russ.).
  16. Artemov AN, Vasilenko IV, Trif JuV, Markina VA. Opyt primenenija Val'doksana pri lechenii trevozhno-depressivnyh rasstrojstv u postinsul'tnyh bol'nyh v rannem vosstanovitel'nom periode. Psihicheskie rasstrojstva v obshhej medicine. 2011;1:42-45. (In Russ.).
  17. Baryl'nik JuB, Filippova NV, Trajber LV. Sovremennye predstavlenija o patogeneticheskih mehanizmah funkcional'nyh narushenij serdechnogo ritma. Vestnik nevrologii, psihiatrii i nejrohirurgii. 2014;8:67-75. (In Russ.).
  18. Baryl'nik JuB, Filippova NV, Trajber LV. Sovremennye podhody k sinhronizacii cirkadiannyh ritmov pri depressii. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014;11:124-128. (In Russ.).
  19. Baryl'nik JuB, Filippova NV, Trajber LV. Sovremennye predstavlenija o patogeneticheskih mehanizmah funkcional'nyh narushenij serdechnogo ritma (nauchnyj obzor). Terapevt. 2014;11:27-33. (In Russ.).
  20. Gavrilova SI, Kolyhalov IV, Ponomareva EV, Selezneva ND. Opyt klinicheskogo primenenija Val'doksana (agomelatina) dlja lechenija depressij u pozhilyh bol'nyh v ambulatornoj praktike. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014;9:29-34. (In Russ.).
  21. Gerdt AM, Gubareva EA, Kramarchuk MV, Gnatyshin VD. Jeffektivnost' i bezopasnost' preparata Val'doksan u pacientov s postinsul'tnoj depressiej. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2011;6:22-26. (In Russ.).
  22. Golubev VL, Pilipovich AA, Gojtemirova PU. Depressija i narushenija sna pri bolezni Parkinsona: rol' Val'doksana v ih korrekcii. Psihicheskie rasstrojstva v obshhej medicine. 2014;1:51-55. (In Russ.).
  23. Gushanskaja EV, Frolova VI, Medvedev VJe. Terapija trevozhnoj depressii (opyt primenenija Val'doksana). Zhurnal psihiatrii i psihofarmakoterapii im. P.B. Gannushkina. 2015;1:17-21. (In Russ.).
  24. Zaika VG, Kudelina OM. Sravnitel'naja ocenka jeffektivnosti Val'doksana (agomelatina), fluoksetina i kombinacii fluoksetina s melaksenom u pacientov s projavlenijami somatogennoj depressii s pomoshh'ju farmakojelektrojencefalografii. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2015;5-6:13-19. (In Russ.).
  25. Ivanov SV. Val'doksan (agomelatin) pri terapii umerennyH i tjazhelyh depRessij nepsihOticheskogo urovNja v ambulatOrnoj i goSpital'noj praktike (rezul'taty Rossijskogo mul'ticentrovogo issledovanija «HRONOS»). Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2009;6:14-17. (In Russ.).
  26. Kuznechenkova LV. Jeffektivnost' i perenosimost' preparata Val'doksan (agomelatin) pri depressivnyh sostojanijah v strukture razlichnyh nozologicheskih form. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2012;4:18-21. (In Russ.).
  27. Marachev MP. Jeffektivnost' agomelatina pri terapii atipichnoj depressii. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2012;3:25-30. (In Russ.).
  28. Medvedev VE. Terapija nepsihoticheskih depressij v ramkah involjucionnoj isterii (opyt primenenija Val'doksana). Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2011;4:14-18. (In Russ.).
  29. Medvedev VE. Primenenie Val'doksana (agomelatin) v kombinirovannoj terapii umerenno vyrazhennyh i tjazhelyh depressij nepsihoticheskogo urovnja. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2012;5:1:37-40. (In Russ.).
  30. Medvedev Ve. Kombinirovannaja terapija depressii Val'doksanom (agomelatin) i antipsihotikami. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2012;2:20-23. (In Russ.).
  31. Medvedev VE. Lechenie bol'shogo depressivnogo rasstrojstva legkoj i srednej stepeni tjazhesti Val'doksanom (agomelatin) v kardiologicheskoj praktike: rezul'taty observacionnoj nacional'noj mul'ticentrovoj programmy «PUL''S». Zhurnal psihiatrii i psihofarmakoterapii im. P.B. Gannushkina. 2014;5:30-35. (In Russ.).
  32. Medvedev VE. Monoterapija disforicheskoj depressii Val'doksanom. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2016;1:20-23. (In Russ.).
  33. Medvedev VE. Vozmozhnost' kombinirovannoj terapii depressij melatoninergicheskim i triciklicheskimi antidepressantami. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2012;1:53-56. (In Russ.).
  34. Medvedev VE, Barsegjan TV. Ocenka jeffektivnosti i perenosimosti antidepressivnoj melatoninjergicheskoj terapii u pacientov, perenesshih hirurgicheskuju korrekciju vneshnosti. Zhurnal nevrologii i psihiatrii im. N.N. Korsakova. 2014;11:2:3-9. (In Russ.). doi: 10.17116/jnevro20141141123-9
  35. Medvedev VE, Gushanskaja EV, Ter-Israeljan AYu. Terapija depressij s javlenijami angedonii (opyt primenenija Val'doksana). Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2014;3:45-49. (In Russ.).
  36. Medvedev VE, Epifanov AV. Terapija depressij u pacientov s gipertonicheskoj bolezn'ju v uslovijah obshhemedicinskogo stacionara. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2012;5:14-18. (In Russ.).
  37. Medvedev VE, Epifanov AV, Larceva OA. Terapija kardionevroza («nejrocirkuljatornaja distonija») v obshhej medicinskoj seti: opyt primenenija preparata Val'doksan. Vrach. 2013;4:66-71. (In Russ.).
  38. Petrova NN. K voprosu o terapii depressii u bol'nyh shizofreniej. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2014;2:25-28. (In Russ.).
  39. Poleckij VM, Kolmogorova VV, Kurkin SD, Darovskih OV, Kushakovskaja EM, Belousova NV. Val'doksan v terapii postshizofrenicheskih depressij. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2013;2:16-22. (In Russ.).
  40. Samushija MA, Mjasnikova LK. Val'doksan (agomelatin) v terapii depressivnyh rasstrojstv u pacientov s onkologicheskimi zabolevanijami organov zhenskoj reproduktivnoj sistemy. Psihicheskie rasstrojstva v obshhej medicine. 2012;3:21-25. (In Russ.).
  41. Smulevich AB, Andrjushhenko AV, Brazhnikov AJu, Zaharova NV, Romanov DV, Samushija MA, Galeckajte JaK, Volel' BA. Jeffektivnost' i bezopasnost' primenenija Val'doksana (agomelatina) pri lechenii depressij v mezhdisciplinarnyh otdelenijah obshhemedicinskoj seti (nabljudatel'naja programma FORUM). Psihicheskie rasstrojstva v obshhej medicine. 2014;2:24-40. (In Russ.).
  42. Stacenko ME, Shilina NN, Turkina SV. Jeffektivnost' primenenija Val'doksana v vosstanovitel'nom periode infarkta miokarda u pacientov s saharnym diabetom 2-go tipa i trevozhno-depressivnymi rasstrojstvami. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2012;6:8-13. (In Russ.).
  43. Trajber LV. Osobennosti psihicheskih narushenij u molodyh muzhchin s predgipertoniej i metody ih korrekcii. Vestnik nevrologii, psihiatrii i nejrohirurgii. 2015;8:46-60. (In Russ.).
  44. Tjuvina NA, Smirnova VN. Jeffektivnost' podderzhivajushhej terapii agomelatinom (val'doksanom) pri rekurrentnoj depressii i bipoljarnom affektivnom rasstrojstve. Psihiatrija i psihofarmakoterapija im. P.B. Gannushkina. 2013;4:30-37. (In Russ.).
  45. Mosolov SN, Kostjukova EG, Ushkalova AV. Klinika i terapija bipoljarnoj depressii. M.: AMA-PRESS; 2009. (In Russ.).
  46. Kopylov FYu, Syrkin AL, Drobizhev MYu, Visurov SA, Medvedev VE. Klinicheskie i psihosomaticheskie osobennosti techenija gipertonicheskoj bolezni v uslovijah hronicheskogo stressa. Klinicheskaja medicina. 2008;2:23-26. (In Russ.).
  47. Medvedev VE, Martynov SE, Zverev KV, Epifanov AV, Hurulov AL, Popovich AA. Psihosomaticheskie zabolevanija v kardiologii (tipologija i kliniko-dinamicheskie harakteristiki). Psihiatrija i psihofarmakoterapija. 2012;4:34-41. (In Russ.).
  48. Syrkin AL, Medvedev VE, Kopylov FYu, Visurov SA. Vlijanie patoharakterologicheskih rasstrojstv na techenie gipertonicheskoj bolezni. Vrach. 2007;4:10-12. (In Russ.).

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.